Novel compounds and methods of using those compounds for the treatment of oncological conditions are provided. In a preferred embodiment, modulation of the activation states of abl or bcr-abl a-kinase proteins comprises the step of contacting the kinase proteins with the novel compounds.
申请公布号
WO2004060305(A3)
申请公布日期
2005.02.10
申请号
WO2003US41425
申请日期
2003.12.26
申请人
DECIPHERA PHARMACEUTICALS, LLC;FLYNN, DANIEL, L.;PETRILLO, PETER, A.
